Catherine Cella

Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

Fast-track colorectal surgery

An integrated multidisciplinary approach to implementation of a fast-track program for laparoscopic colorectal surgery

Pharmacology and Management of the Vitamin K Antagonists

Assessment of laboratory assays to measure rivaroxaban – an oral, direct factor Xa inhibitor

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves

Oral Anticoagulant Therapy

Daily vitamin K supplementation improves anticoagulant stability

Pharmacogenomics of 4-Hydroxycoumarin Anticoagulants

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

Checking consistency in mixed treatment comparison meta‐analysis

Mixed Comparison of Stroke Prevention Treatments in Individuals With Nonrheumatic Atrial Fibrillation

Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Thromboembolic Consequences of Subtherapeutic Anticoagulation in Patients Stabilized on Warfarin Therapy: The Low INR Study

Effect of Study Setting on Anticoagulation Control

Idarucizumab for Dabigatran Reversal

Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation

The Pharmacology and Management of the Vitamin K Antagonists

Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy

Atrial fibrillation and stroke prevention

Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays

French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding)

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation

Cyclo-oxygenase 2 inhibitors and the risk of anastomotic leakage after fast-track colonic surgery

Randomized clinical trial on the effect of coffee on postoperative ileus following elective colectomy

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Guidelines for Perioperative Care in Elective Colonic Surgery: Enhanced Recovery After Surgery (ERAS^®) Society Recommendations

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS^®) Society Recommendations

Evidence-Based Surgical Care and the Evolution of Fast-Track Surgery

Antimicrobial Resistance in ESKAPE Pathogens

Warfarin Anticoagulation and Outcomes in Patients With Atrial Fibrillation

PCV8 WARFARIN ANTICOAGULATION AND OUTCOMES IN ATRIAL FIBRILLATION PATIENTS:A SYSTEMATIC REVIEW AND META-ANALYSIS

Minimally Invasive Colorectal Resection Outcomes: Short-term Comparison with Open Procedures